HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Nakaraang pagsara
₹835.45
Sakop ng araw
₹795.00 - ₹836.05
Sakop ng taon
₹684.35 - ₹1,997.40
Market cap
40.53B INR
Average na Volume
89.92K
P/E ratio
36.53
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 2.17B | -1.47% |
Gastos sa pagpapatakbo | 747.93M | 3.12% |
Net na kita | 207.75M | -29.41% |
Net profit margin | 9.56 | -28.34% |
Kita sa bawat share | — | — |
EBITDA | 257.00M | -35.44% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.44B | 384.25% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 12.24B | — |
Natitirang share | 50.67M | — |
Presyo para makapag-book | 3.46 | — |
Return on assets | — | — |
Return on capital | 3.20% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 207.75M | -29.41% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Orchid Pharma Limited is an Indian pharmaceutical chimpanzee based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Itinatag
1992
Website
Mga Empleyado
871
